In populations of adults with overweight or obesity, use of tirzepatide was associated with significantly greater weight loss than semaglutide [26] [27], suggesting that the superior efficacy observed in controlled trials translates to clinical practice
Private label manufacturing offers brands the opportunity to market and sell liposomal glutathione supplements under their own brand name, building brand recognition and customer loyalty
Wegovy (semaglutide injection): A renowned GLP-1 medication, Wegovy facilitates significant weight loss by imitating natural hormones that suppress appetite
Notably, such a stereoisomeric control is difficult to develop with thalidomide-based degraders, which are often prone to fast racemization in situ 110
Increased Risk of Thyroid Tumors and Medullary Thyroid Carcinoma Some lawsuits allege that GLP-1 medications increase the risk of thyroid tumors and medullary thyroid carcinoma, a rare but aggressive form of thyroid cancer